Open Access

[Corrigendum] Dl‑3‑n‑butylphthalide alleviates cognitive impairment in amyloid precursor protein/presenilin 1 transgenic mice by regulating the striatal‑enriched protein tyrosine phosphatase/ERK/cAMP‑response element‑binding pro‑​tein signaling pathway

  • Authors:
    • Yan Zhao
    • Wen-Qiang Yang
    • Lu Yu
    • Jing Yang
    • Hai-Rong Zhu
    • Lin Zhang
  • View Affiliations

  • Published online on: November 30, 2022     https://doi.org/10.3892/etm.2022.11742
  • Article Number: 43
  • Copyright : © Zhao et al. This is an open access article distributed under the terms of Creative Commons Attribution License [CC BY 4.0].

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )


Article

Exp Ther Med 23:[Related article:] 319, 2022; DOI: 10.3892/etm.2022.11248

Subsequently to the publication of the above article, an interested reader drew to the authors’ attention that, in Fig. 6C on p. 8, the data panels showing the ‘Hippocampus / APP/PS1’ and ‘Hippocampus / NBP 30 mg/kg’ experiments appeared to be overlapping, such that these may have been derived from the same original source.

The authors had retained acess to their original data, and were able to identify that the affected panels were inadvertently assembled incorrectly in this figure; specifically, the data panel for the ‘Hippocampus / APP/PS1’ experiment was chosen incorrectly. The revised version of Fig. 6 is shown on the next page, now featuring the correct data panel for the ‘Hippocampus / APP/PS1’ experiment. Note that this error did not have a major impact on either the overall results or on the conclusions reported in this study. The authors thank the interested reader for bringing this matter to their attention. All the authors agree with the publication of this corrigendum, and are grateful to the Editor of Experimental and Therapeutic Medicine for granting them the opportunity to publish this; furthermore, they apologize to the readership for any inconvenience caused.

Related Articles

Journal Cover

January-2023
Volume 25 Issue 1

Print ISSN: 1792-0981
Online ISSN:1792-1015

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
x
Spandidos Publications style
Zhao Y, Yang W, Yu L, Yang J, Zhu H and Zhang L: [Corrigendum] Dl‑3‑n‑butylphthalide alleviates cognitive impairment in amyloid precursor protein/presenilin 1 transgenic mice by regulating the striatal‑enriched protein tyrosine phosphatase/ERK/cAMP‑response element‑binding pro‑​tein signaling pathway. Exp Ther Med 25: 43, 2023.
APA
Zhao, Y., Yang, W., Yu, L., Yang, J., Zhu, H., & Zhang, L. (2023). [Corrigendum] Dl‑3‑n‑butylphthalide alleviates cognitive impairment in amyloid precursor protein/presenilin 1 transgenic mice by regulating the striatal‑enriched protein tyrosine phosphatase/ERK/cAMP‑response element‑binding pro‑​tein signaling pathway. Experimental and Therapeutic Medicine, 25, 43. https://doi.org/10.3892/etm.2022.11742
MLA
Zhao, Y., Yang, W., Yu, L., Yang, J., Zhu, H., Zhang, L."[Corrigendum] Dl‑3‑n‑butylphthalide alleviates cognitive impairment in amyloid precursor protein/presenilin 1 transgenic mice by regulating the striatal‑enriched protein tyrosine phosphatase/ERK/cAMP‑response element‑binding pro‑​tein signaling pathway". Experimental and Therapeutic Medicine 25.1 (2023): 43.
Chicago
Zhao, Y., Yang, W., Yu, L., Yang, J., Zhu, H., Zhang, L."[Corrigendum] Dl‑3‑n‑butylphthalide alleviates cognitive impairment in amyloid precursor protein/presenilin 1 transgenic mice by regulating the striatal‑enriched protein tyrosine phosphatase/ERK/cAMP‑response element‑binding pro‑​tein signaling pathway". Experimental and Therapeutic Medicine 25, no. 1 (2023): 43. https://doi.org/10.3892/etm.2022.11742